Continue to Limit Celecoxib and Other NSAIDs in High-CV-Risk Patients

Debate will continue about whether it's okay to use celecoxib (Celebrex, etc) in patients at high cardiovascular risk.

We're used to thinking that COX-2 inhibitors have a higher CV risk than other NSAIDs...especially since rofecoxib (Vioxx) was withdrawn due to an increased risk of heart attacks and strokes.

But celecoxib's CV risk may not be higher than other NSAIDs.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote